Medco Tops Fortune's Lists of 'World's Most Admired' Companies

Medco Health Solutions, Inc. (NYSE: MHS), captured the No. 1 position within the Health Care: Pharmacy and Other Services sector on

Fortune

’s World’s Most Admired Companies List. In addition, of all companies surveyed globally, Medco was ranked No. 5 in Innovation and No. 10 in People Management.

“To be ranked highest among our industry peers is a great honor that underscores the pioneering spirit of our people in forging a future in healthcare that improves clinical and financial outcomes for our clients and their members,” said Medco Chairman and CEO David B. Snow, Jr.

Fortune

, in partnership with the Hay Group, surveyed more than 650 companies across 64 industry sectors worldwide. To establish the rankings, company executives, board directors and outside analysts were asked to rate companies in their own industry on nine criteria, from investment value to social responsibility. Results are featured in the March 16th issue of

Fortune

magazine.

According to the

Fortune

survey, Medco received several industry and global honors:

No. 1 World’s Most-Admired: “Health Care: Pharmacy and Other Services” category— with the industry’s highest rank in seven attributes: innovation, people management, use of corporate assets, quality of management, financial soundness, quality of products/services and global competitiveness.
No. 2 in the world in the “Health Care: Pharmacy and Other Services” category for social responsibility and long-term investment.
No. 5 globally in Innovation.
No. 10 globally for People Management.
Among the most admired companies in New Jersey.

“Medco’s more than 20,000 employees are honored to earn a place on

Fortune

’s list of the world’s most innovative companies. We are, however, even more gratified by the trust and confidence of our clients and their members as we continue to innovate around pharmacy practices that enable a new era of precision medicine—serving as a catalyst for healthcare reform in America,” continued Snow.

Medco is redefining the practice of pharmacy by training more than 1,000 of its specialist pharmacists to help improve the quality of care for patients with chronic and complex conditions—patients who account for 96 percent of drug spending and 75 percent of overall medical spending. These pharmacists are better positioned to identify safety issues and consult more effectively with doctors to improve clinical and financial outcomes. The specialist pharmacists work within

Medco Therapeutic Resource Centers

Ž located nationwide and focused on major conditions that include diabetes, oncology, arthritis, high blood pressure, high cholesterol and neurology/psychology.

Medco is focused on closing gaps in clinical care, improving patient health and lowering overall medical costs. This is accomplished by partnering with member advocacy programs to engage and educate consumers, pharmacogenomics research that helps physicians in the selection of the right medicine and dose based on a patient’s unique genetic make-up as well as other clinical initiatives.